Trials / Completed
CompletedNCT02250482
An Open Study to Investigate the Safety and Efficacy of Optivate® in Haemophilia A Patients Undergoing Surgery.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- Bio Products Laboratory · Academic / Other
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
The main objective of the study is to investigate the safety and efficacy of Optivate®, administered in appropriate dosage to present bleeding and achieve haemostasis in patients with Haemophilia A undergoing surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Optivate® (Human Coagulation Factor VIII) |
Timeline
- Start date
- 2001-11-01
- Primary completion
- 2003-08-01
- First posted
- 2014-09-26
- Last updated
- 2018-02-15
Locations
8 sites across 2 countries: Poland, United Kingdom
Source: ClinicalTrials.gov record NCT02250482. Inclusion in this directory is not an endorsement.